Hologic (NASDAQ:HOLX) had its price objective hosited by ISI Group from $24.50 to $26.50 in a report released on Thursday, AnalystRatings.Net reports. ISI Group currently has a strong-buy rating on the stock.
HOLX has been the subject of a number of other recent research reports. Analysts at Jefferies Group cut their price target on shares of Hologic from $26.00 to $24.00 in a research note to investors on Tuesday, November 12th. They now have a buy rating on the stock. Separately, analysts at Cantor Fitzgerald cut their price target on shares of Hologic from $21.00 to $19.00 in a research note to investors on Tuesday, November 12th. They now have a hold rating on the stock. Finally, analysts at Citigroup Inc. reiterated a neutral rating on shares of Hologic in a research note to investors on Tuesday, November 12th. They now have a $22.00 price target on the stock, down previously from $24.00. Two equities research analysts have rated the stock with a sell rating, twelve have assigned a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. The company currently has an average rating of Hold and a consensus target price of $22.10.
Hologic (NASDAQ:HOLX) traded down 0.02% during mid-day trading on Thursday, hitting $22.70. 780,005 shares of the company’s stock traded hands. Hologic has a 52 week low of $18.46 and a 52 week high of $23.96. The stock has a 50-day moving average of $21.91 and a 200-day moving average of $21.27.
Hologic (NASDAQ:HOLX) last posted its quarterly earnings results on Monday, November 11th. The company reported $0.39 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.02. The company had revenue of $622.10 million for the quarter, compared to the consensus estimate of $624.40 million. During the same quarter last year, the company posted $0.37 earnings per share. Hologic’s revenue was up 3.6% compared to the same quarter last year. Analysts expect that Hologic will post $1.39 EPS for the current fiscal year.
Hologic, Inc is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products to serving the healthcare needs of women.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.